Who
Jean-Claude Kyrillos
EVP & Chief Operating Officer
Company insider
Files Form 4 as: EVP & Chief Operating Officer, Tandem Diabetes Care; Senior Vice President, Envista Holdings.
In numbers
- Trades disclosed
- 65
- Buys
- 1
- Sells
- 0
- Bought
- $191K
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 25 Feb 2020
- Last trade
- 15 Oct 2026
- Last filed
- 19 Oct 2026
Companies traded
Activity over time
1 Mar 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Oct 2026filed 19 Oct 2026 | TNDM Tandem Diabetes CareMedical Devices | SEC FORM 4 Code M | —3,637 at $0.00 | filing |
| 15 Oct 2026filed 19 Oct 2026 | TNDM Tandem Diabetes CareMedical Devices | SEC FORM 4 Code F | $32K1,926 at $16.52 | filing |
| 15 Oct 2026filed 19 Oct 2026 | TNDM Tandem Diabetes Careoption or derivative · Medical Devices | SEC FORM 4 Code M | —3,637 at $0.00 | filing |
| 15 Aug 2026filed 18 Aug 2026 | TNDM Tandem Diabetes CareMedical Devices | SEC FORM 4 Code M | —1,010 at $0.00 | filing |
| 15 Aug 2026filed 18 Aug 2026 | TNDM Tandem Diabetes CareMedical Devices | SEC FORM 4 Code F | $12K535 at $22.72 | filing |
| 15 Aug 2026filed 18 Aug 2026 | TNDM Tandem Diabetes Careoption or derivative · Medical Devices | SEC FORM 4 Code M | —1,010 at $0.00 | filing |
| 15 Aug 2026filed 18 Aug 2026 | TNDM Tandem Diabetes Careoption or derivative · Medical Devices | SEC FORM 4 Code M | —1,010 at $0.00 | filing |
| 15 Aug 2026filed 18 Aug 2026 | TNDM Tandem Diabetes CareMedical Devices | SEC FORM 4 Code M | —1,010 at $0.00 | filing |
| 15 Aug 2026filed 18 Aug 2026 | TNDM Tandem Diabetes CareMedical Devices | SEC FORM 4 Code F | $12K535 at $22.72 | filing |
| 15 Jul 2026filed 17 Jul 2026 | TNDM Tandem Diabetes CareMedical Devices | SEC FORM 4 Code M | —3,636 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | TNDM Tandem Diabetes CareMedical Devices | SEC FORM 4 Code F | $29K1,926 at $15.28 | filing |
| 15 Jul 2026filed 17 Jul 2026 | TNDM Tandem Diabetes Careoption or derivative · Medical Devices | SEC FORM 4 Code M | —3,636 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | TNDM Tandem Diabetes Careoption or derivative · Medical Devices | SEC FORM 4 Code M | —3,636 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | TNDM Tandem Diabetes CareMedical Devices | SEC FORM 4 Code M | —3,636 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | TNDM Tandem Diabetes CareMedical Devices | SEC FORM 4 Code F | $29K1,926 at $15.28 | filing |
| 29 May 2026filed 2 Jun 2026 | TNDM Tandem Diabetes Careoption or derivative · Medical Devices | SEC FORM 4 Code A | —29,136 at $0.00 | filing |
| 29 May 2026filed 2 Jun 2026 | TNDM Tandem Diabetes Careoption or derivative · Medical Devices | SEC FORM 4 Code A | —29,136 at $0.00 | filing |
| 15 May 2026filed 19 May 2026 | TNDM Tandem Diabetes CareMedical Devices | SEC FORM 4 Code M | —4,038 at $0.00 | filing |
| 15 May 2026filed 19 May 2026 | TNDM Tandem Diabetes CareMedical Devices | SEC FORM 4 Code F | $27K2,139 at $12.82 | filing |
| 15 May 2026filed 19 May 2026 | TNDM Tandem Diabetes CareMedical Devices | SEC FORM 4 Code A | $4,731434 at $10.90 | filing |
News
Tandem Diabetes Care (TNDM) Following App Recall Is The Undervalued Case Still IntactTNDM · cedarnews.net · 18 Oct 2026
0 headlines in the last 90 days name Jean-Claude Kyrillos; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.